Wednesday, 19 February 2014

Metabolism, Diet and Disease 2014: Cancer and Metabolism

Metabolism, Diet and Disease 2014: Cancer and metabolism

BioMed Central will host the second biennial Metabolism, Diet and Disease: Cancer and metabolism conference on 28th to 30th May 2014 in Washington DC, USA. Please note that there has been a recent change of venue and we are delighted to be returning to theGeorgetown University Hotel & Conference Center. The conference is supported by the journalsBMC Biology and BMC Medicine, which celebrate their 10th Anniversary in 2013, and Cancer & Metabolism.  Following the success of the first Metabolism, Diet and Disease conference in 2012, this second conference will bring together leading researchers in cancer and metabolism with experts in whole-body metabolism.
Internationally recognized speakers will talk on topics which will include metabolic links to cancer, obesity and diabetes, oncogenic drivers and vulnerabilities in altered cancer cell metabolism, the metformin paradox – biguanides and energy metabolism, and metabolism-based cancer therapies. Following the lively panel discussion in 2012, the 2014 panel topic will be ‘Is cancer preventable? The influence of diet on cancer’ chaired by Gregory Petsko.
All participants are invited to submit abstracts for oral and poster presentations. Submitted abstracts will be published as a supplement in Cancer & Metabolism and indexed in PubMed and by ISI Web of Science.
Registrants for the ‘Metabolism, Diet and Disease’ conference are entitled to a 15% discount on article processing charges for publications in the BMC Biology, BMC Medicine,  Cancer & Metabolismjournals and all other BioMed Central journals. The offer will apply until 31 August 2014.

Organizing committee

Craig Thompson

Craig Thompson

Memorial Sloan-Kettering Cancer Center, USA
J. Michael Bishop

J Michael Bishop

University of California San Francisco, USA
Chi-Van-Dang

Chi Van Dang

Abramson Cancer Center, USA
David Sabatini

David Sabatini

Massachusetts Institute of Technology, USA
Michael Pollak

Michael Pollak

McGill University and Jewish General Hospital, Canada
Joseph L Goldstein

Joseph L Goldstein

University of Texas Southwestern Medical Center, USA
Lewis Cantley

Lewis Cantley

Weill Cornell Medical College and New York-Presbyterian Hospital, USA
Michael S Brown

Michael S Brown

University of Texas Southwestern Medical Center, USA

Speakers & panel

J Michael Bishop

J Michael Bishop

University of California San Francisco, USA
Lewis Cantley

Lewis Cantley

Weill Cornell Medical College and New York-Presbyterian, USA
Navdeep Chandel

Navdeep Chandel

Northwestern University,Chicago, USA
Chi Van Dang

Chi Van Dang

Abramson Cancer Center, USA
Ralph DeBerardinis

Ralph DeBerardinis

University of Texas Southwestern Medical Center, USA
Eugene Fine

Eugene Fine

Albert Einstein College of Medicine, USA
Grahame Hardie

Grahame Hardie

University of Dundee, UK
Matthew Vander Heiden

Matthew Vander Heiden

Massachusetts Institute of Technology, USA
Judy Hirst

Judy Hirst

MRC Mitochondrial Biology Unit, Cambridge, UK
William G Kaelin

William G Kaelin

Dana-Farber Cancer Institute, USA
Barbara Kahn

Barbara Kahn

Harvard Medical School and Beth Israel Deaconess Hospital, USA
David Mangelsdorf

David Mangelsdorf

University of Texas Southwestern Medical Center, USA
Steven McKnight

Steven McKnight

University of Texas Southwestern Medical Center, USA
Gregory Petsko

Gregory Petsko

Weill Cornell Medical College and Brandeis University, USA
Michael Pollak

Michael Pollak

McGill University and Jewish General Hospital, Canada
Joshua D Rabinowitz

Joshua D Rabinowitz

Princeton University, USA
Peter J Ratcliffe

Peter J Ratcliffe

University of Oxford, UK
Elio Riboli

Elio Riboli

Imperial College London, UK
David Sabatini

David Sabatini

Massachusetts Institute of Technology, USA
Reuben Shaw

Reuben Shaw

Salk Institute, USA
Craig Thompson

Craig Thompson

Memorial Sloan-Kettering Cancer Center, USA
Karen Vousden

Karen Vousden

Beatson Institute for Cancer Research, Glasgow, UK
Eileen White

Eileen White

Rutgers Cancer Institute of New Jersey, USA

BioMed Central

BioMed Central is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
Distributed by BioMed

No comments:

Post a Comment